Virtual peer mentoring aims to boost cervical cancer screening in ethiopian HIV clinics
NCT ID NCT07678047
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tests whether a virtual training and peer-mentoring program called Project ECHO can help healthcare providers in Ethiopia improve cervical cancer screening and treatment for women living with HIV. The program focuses on using HPV self-sampling, a simpler screening method. Researchers will compare screening and treatment rates before and after the training to see if it makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Project ECHO (virtual training and peer-mentoring program)
- What this could lead to
- If successful, this approach could improve cervical cancer screening and treatment rates for women with HIV in low-resource settings, potentially saving lives.
- What could go wrong
- This is a small, early-stage implementation study with only 60 participants, so results may not apply broadly. The training program may not lead to lasting changes in clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Jul 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria for Project ECHO and associated surveys, interviews, and focus group discussions: * 18 years or older * Willingness and ability to provide informed consent and participate in virtual, peer-mentoring through Project ECHO * Profession: Healthcare provider, any education/training/cadre with experience relevant to the delivery of cervical cancer screening and treatment or HIV care (e.g., cervical cancer screening, gynecologist, gynecological oncologist, or HIV/ ART provider), or other stakeholder (e.g., personnel at laboratories or health bureaus, administrators, ART data clerks) * Can communicate in English or Amharic (national language of Ethiopia) * Able and willing to meaningfully contribute in the virtual, peer-learning community of Project ECHO Inclusion criteria for end service users (PLHIV) for focus group discussion and routine clinical service delivery data: * 25 years or older (in accordance with Ethiopia's national cervical cancer screening guidelines for PLHIV) * Have been diagnosed with HIV * Have a history of cervical cancer screening that was performed at one of the five study sites, either during the course of our study or previously * Were screened with primary HPV DNA testing during the course of the study intervention period * Are eligible for cervical cancer screening in accordance with Ethiopia's national cervical cancer screening guidelines (e.g., have an intact cervix) Exclusion criteria for end service users (PLHIV) for focus group discussion: * HIV negative status * Age under 25 years * Any physical or mental disability that prevents the individual from consenting to cervical cancer screening and/or study participation * Patients without an intact cervix (e.g. a history of hysterectomy) * Anyone ineligible for cervical cancer screening in accordance with Ethiopia's national cervical cancer screening guidelines Note: Routine clinical service delivery data of PLHIV will be reviewed to determine intervention effect of providers participating in Project ECHO. PLHIV are not considered participants of the trial and are not consented.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Addis Ababa University
Addis Ababa, Ethiopia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Once-Daily HIV pill with food match Twice-Daily dosing during TB treatment?
- Four weeks vs twelve weeks: can a shorter TB prevention course work?
- Can a phone app keep young people with HIV engaged in care?
- Massive Real-World database aims to map how chronic diseases interact
- How do HIV drugs behave when kidneys fail? study measures blood levels
- Can HIV-Positive mothers breastfeed without passing the virus to their babies?